Andrew M. Kaunitz

Menopausal Hormone Therapy and Ovarian Cancer Risk

Although ovarian cancer is uncommon, late diagnosis makes this tumor the most lethal gynecologic malignancy. In this U.K. prospective cohort study,

Aromatase Inhibitors and Arthralgias

Adjuvant use of aromatase inhibitors (AIs) extends disease-free survival and is considered to be safe for postmenopausal women with early-stage,

Lengthened WHI Follow-Up: Postmenopausal Estrogen Therapy

In the Womens Health Initiative (WHI) Estrogen-Alone Trial, 11,000 postmenopausal women with hysterectomies (age range at baseline, 50–79) received

An HPV Vaccine -- At Last!

Infection with human papillomavirus (HPV) is a major risk factor for preinvasive and invasive cervical cancer. In this randomized, multicenter,

How Does Hormone Therapy Affect Breast Cancer Risk After Oophorectomy in

Prophylactic bilateral oophorectomy lowers risk for ovarian cancer in women with BRCA1 mutations; however, carriers may be reluctant to use menopausal

Hysterectomy: When Practice Makes Perfect

Patients treated by higher-volume surgeons have superior perioperative outcomes (NEJM JW Womens Health Sep 2016) and Am J Obstet Gynecol 2016; 215:21)

Teasing Out the Association Between Premenopausal BMI and Breast Cancer Risk

Higher body-mass index (BMI) has been associated with lower risk for premenopausal breast cancer but higher risk for postmenopausal breast cancer. To

Vaginal Estrogen: Revisiting Conventional Wisdom

Declining estrogen levels underlie genitourinary syndrome of menopause (GSM, previously termed vulvovaginal atrophy), a common progressive condition

Risk for Contralateral Breast Cancer — A Family Affair?

Among breast cancer survivors, risk for a second primary malignancy is greater than risk for a first breast cancer in the general population. To assess

Embracing Minimally Invasive Surgical Treatment for Endometrial Cancer

Although minimally invasive (laparoscopic, including robotic) approaches have been shown to improve perioperative outcomes for benign and malignant